A platinum(iv) prodrug to defeat breast cancer through disrupting vasculature and inhibiting metastasis.

Authors :: Guo, Yan
Zhang, Shuren
Yuan, Hao
Song, Dongfan
Jin, Suxing
Guo, Zijian
Wang, Xiaoyong
Source :: Dalton Transactions: An International Journal of Inorganic Chemistry. 3/21/2019, Vol. 48 Issue 11, p3571-3575. 5p.
Publication Year :: 2019
Abstract: A PtIV prodrug (PDMA) exhibits great potential for the therapy of metastatic triple-negative breast cancer (TNBC) through a synergistic action of antiangiogensis and antimetastasis. [ABSTRACT FROM AUTHOR]

Subjects :: *PLATINUM
*BREAST cancer
*METASTATIC breast cancer
*TRIPLE-negative breast cancer

Language :: English
ISSN :: 14779226
Volume :: 48
Issue :: 11
Database :: Academic Search Index
Journal :: Dalton Transactions: An International Journal of Inorganic Chemistry
Publication Type :: Academic Journal
Accession number :: 135264018
Full Text :: https://doi.org/10.1039/c9dt00335e

Full Text Access

Tools